News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

America Stem Cell, Inc. (Helotes, TX) Initiates a Phase I/II Trial of ASC-101 in Patients With Hematologic Malignancies Undergoing Dual-Cord Transplantation



8/28/2012 9:54:51 AM

SAN ANTONIO--(BUSINESS WIRE)--America Stem Cell, Inc. announced today the initiation of a single-center study at The University of Texas MD Anderson Cancer Center evaluating ASC-101 in dual-umbilical cord transplantation in patients with hematologic malignancies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES